Financial Data and Key Metrics Changes - For full year 2024, total revenues increased to just over $5 million, a 13% increase compared to 2023, driven by a 46% increase in Zola sales despite a 49% decline in GLA oil sales [8][24] - Q4 total revenues were approximately $1.2 million, representing a 56% increase year-over-year, with Zola revenues increasing by 124% in Q4 [23][24] - Gross margin rate declined from 51% in 2023 to 41% in 2024, with Q4 gross margin at 32% [24][25] Business Line Data and Key Metrics Changes - Zola sales increased 46% for the full year 2024, with a significant 80% growth in the second half of the year [11][13] - GLA sales for the full year were $756,000, with Q4 sales at $55,000, and the company is completely sold out of GLA inventory as of December 31, 2024 [38] Market Data and Key Metrics Changes - The shelf-stable coconut water category grew 28.7% in the four weeks ending December 28, 2024, while Zola's growth was 73.7% during the same period [14] - For the full year, the coconut water category grew 18.5%, while Zola increased by 38.5% [15] Company Strategy and Development Direction - The company has focused on simplifying its business by exiting underperforming Body Care brands and concentrating on Zola coconut water products [6][7] - The strategy has resulted in a leaner company with reduced operating expenses and a focus on profitable growth [12][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in Zola's momentum entering 2025, supported by new distribution gains from the second half of 2024 [17][45] - The company aims to maintain tight cost controls while expanding revenues, achieving gross margins above 30% for eight consecutive quarters [45] Other Important Information - The company ended 2024 with $4.2 million in cash, down from $11.6 million at the start of the year, but managed to reduce operating cash consumption in the second half [28][31] - A pending transaction with Roosevelt Resources is expected to be completed towards the end of Q2 2025 [20][19] Q&A Session Summary Question: Expectations for continued Zola distribution growth in 2025 - Management indicated a healthy pipeline for distribution growth in 2025, benefiting from full-year impact of new distribution established in 2024 [36] Question: Full year GLA revenue and confirmation of inventory status - Full year GLA revenue was $756,000, with Q4 revenue at $55,000, confirming that the company is completely out of GLA inventory as of December 31, 2024 [38] Question: Status of monetizing legacy IP from prior business model - Management is in advanced discussions to monetize the wheat patent portfolio, expecting to complete transactions in the first half of the year [40][42]

Financial Data and Key Metrics Changes - The company reported a 5.1% revenue growth for the full year, with constant currency revenue growth of 4.8%, slightly below guidance due to sluggish category growth [34] - Adjusted EBITDA for the fourth quarter was a loss of CHF 6.1 million, and for the full year, it was a loss of CHF 35.3 million, which was at the favorable end of the guidance range [34][35] - Gross margin expanded by 9.3 percentage points year-over-year, reaching 28.7% for the full year [34][70] Business Line Data and Key Metrics Changes - Each of the three operating segments reported profitable growth for the second consecutive quarter, with solid volume growth in both the fourth quarter and full year [37] - The Barista portfolio remains the largest business and growth driver, with North America reporting 10% growth and Europe and International reporting 13% growth in 2024 [15][18] Market Data and Key Metrics Changes - North America experienced double-digit revenue growth in retail and 8% growth in foodservice, with foodservice sales growing by 22% when excluding the largest customer [16][19] - Greater China posted strong double-digit growth in the second half of the year after a strategic reset, driven by an expanded presence in the foodservice channel [16][87] Company Strategy and Development Direction - The company aims to ignite category momentum by increasing relevance and attacking barriers to conversion from dairy, while also driving efficiencies [13][14] - A focus on supply chain simplification has been emphasized, with the closure of the Singapore facility and discontinuation of a second Chinese facility, maintaining five global manufacturing plants [9][30] Management's Comments on Operating Environment and Future Outlook - Management expects to enter a profitable growth era in 2025, with constant currency revenue growth projected between 2% to 4% [7][41] - The company anticipates a 300 basis point headwind to growth from sourcing changes at its largest U.S. customer, but underlying growth remains healthy [7][41] Other Important Information - The company achieved a 99% customer fill rate in 2024, indicating improved operational efficiency [9] - Free cash flow improved significantly, with a $156 million use of cash for the year, marking the best performance since the IPO [39] Q&A Session Summary Question: What are the drivers within gross margin improvement? - Management highlighted optimizing production footprint, maximizing global sourcing resources, and managing product mix as key drivers for gross margin improvement [50][51] Question: What is the outlook for promotional activity in the U.S.? - Management acknowledged recent volatility in promotional activity but emphasized solid consistent velocities in core portfolio products and expected steady growth trajectory [52][55] Question: What is the risk associated with the largest customer in the U.S.? - Management noted that the largest customer represents only 20% of U.S. sales and 7% of total company sales, indicating a reduced exposure and ongoing efforts to drive growth outside this customer [58][83] Question: How has the outlook for the Chinese market changed? - Management confirmed that the business in Greater China is showing positive trends, with profitable growth reported since Q3 2024, and plans to enter the club channel in 2025 [86][87] Question: How confident is the company in achieving the low end of EBITDA guidance for 2025? - Management expressed confidence in the plans being fully resourced and emphasized a disciplined approach to cost and capital allocation to achieve the guidance [92][96]

Financial Data and Key Metrics Changes - Revenue for Q1 2024 totaled $5.8 million, an increase of 53% compared to $3.8 million in Q1 2023 [10] - Gross margin improved to 73% for Q1 2024, up from 67% in the same period last year [11] - Operating loss for Q1 2024 was $1.1 million, an improvement of $928,000 compared to the same period last year [11] - Net loss decreased to $4.5 million in Q1 2024 from $13.1 million in Q1 2023 [11] - Adjusted EBITDA loss was $59,000 for Q1 2024, a significant improvement from a $1.8 million loss in Q1 2023 [12] Business Line Data and Key Metrics Changes - Revenue from the Ultramist line increased by 81% year-on-year [6] - Revenue from consumable applicators increased by 64% year-on-year and 14% sequentially from Q4 2023 [6] - Active systems in the field reached 709, with Ultramist systems sold up by 54 units compared to Q1 2023 [5][6] Market Data and Key Metrics Changes - The company noted a seasonal slowdown in system sales during Q1, which is typical in the medical device industry [7] - The company aims to reduce applicator revenues as a percentage of total revenues to a range of 55% to 65% as system sales increase [6][7] Company Strategy and Development Direction - The company is focused on expanding its geographic footprint and engaging larger customers [7] - There is a strategic emphasis on deeper customer engagement, particularly in nursing homes and acute care settings [8] - The company is optimistic about 2024 being a breakout year, with plans to execute on growth strategies [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 45% to 55% year-on-year growth in Q2 and reiterated a 50% growth guidance for fiscal year 2024 [16] - The company is addressing delays in the SEPA merger, with a path to closing expected before May 31 [14][15] Other Important Information - The company has hired additional sales and operational staff to support growth initiatives [7] - The management highlighted the importance of price discipline and manufacturing improvements to enhance gross margins [5] Q&A Session Summary - There were no questions from participants during the Q&A session, indicating that the management may have addressed all concerns thoroughly [19]